TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 233 filers reported holding TWIST BIOSCIENCE CORP in Q4 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,220 | +3.7% | 11,860 | +5.6% | 0.00% | – |
| Q2 2023 | $231,726 | +63.9% | 11,227 | +17.0% | 0.00% | – |
| Q1 2023 | $141,425 | -24.2% | 9,593 | +22.0% | 0.00% | – |
| Q4 2022 | $186,692 | +32.4% | 7,862 | +95.9% | 0.00% | – |
| Q3 2022 | $141,000 | +4.4% | 4,014 | +7.1% | 0.00% | – |
| Q2 2022 | $135,000 | +141.1% | 3,747 | +12.4% | 0.00% | – |
| Q1 2022 | $56,000 | -83.8% | 3,334 | -20.8% | 0.00% | -100.0% |
| Q4 2021 | $346,000 | -16.4% | 4,212 | +7.8% | 0.00% | 0.0% |
| Q3 2021 | $414,000 | -14.5% | 3,907 | +6.4% | 0.00% | 0.0% |
| Q2 2021 | $484,000 | +14.7% | 3,672 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $422,000 | -21.0% | 3,458 | -8.5% | 0.00% | 0.0% |
| Q4 2020 | $534,000 | +2442.9% | 3,780 | +1348.3% | 0.00% | – |
| Q3 2020 | $21,000 | +50.0% | 261 | -13.0% | 0.00% | – |
| Q2 2020 | $14,000 | +133.3% | 300 | +50.0% | 0.00% | – |
| Q1 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 1,104,214 | $156,015,000 | 38.36% |
| Blue Water Life Science Advisors, LP | 146,356 | $20,678,000 | 6.16% |
| Casdin Capital, LLC | 1,000,000 | $141,290,000 | 4.19% |
| BRANDYWINE MANAGERS, LLC | 18,988 | $2,683,000 | 3.69% |
| Capital Impact Advisors, LLC | 97,000 | $13,705,000 | 3.36% |
| Brevan Howard Capital Management LP | 112,000 | $15,824,000 | 3.17% |
| ARK Investment Management | 5,876,971 | $830,357,000 | 2.21% |
| Nicholas Investment Partners, LP | 178,875 | $25,273,000 | 1.95% |
| Nikko Asset Management Americas, Inc. | 1,840,306 | $260,017,000 | 1.48% |
| Intellectus Partners, LLC | 28,058 | $3,964,000 | 1.19% |